betway必威登陆网址 (betway.com )学报››2022,Vol. 43››Issue (12): 911-917.DOI:10.3969/j.issn.2097-0005.2022.12.006
王猛(), 李培瑞, 卢新霞, 王英杰, 纪龙, 李晓梅, 丁国永, 齐艳波, 邢薇佳, 侯海峰, 王芳, 邓阳, 李栋(
)
收稿日期:
2022-07-28出版日期:
2022-12-25发布日期:
2023-02-08通讯作者:
李栋作者简介:
王猛,硕士研究生,研究方向:慢性病与糖基组学, E-mail:wangm2211@163.com。基金资助:
Meng WANG(), Peirui LI, Xinxia LU, Yingjie WANG, Long JI, Xiaomei LI, Guoyong DING, Yanbo QI, Weijia XING, Haifeng HOU, Fang WANG, Yang DENG, Dong LI(
)
Received:
2022-07-28Online:
2022-12-25Published:
2023-02-08Contact:
Dong LI摘要:
目的探索山东省高校大学生疫情期间心理应激反应与免疫球蛋白G N-聚糖之间的相关性。方法根据纳入、排除标准选取疫情期间betway必威登陆网址 在读学生150例为研究对象。使用SRQ问卷调查大学生心理应激水平,采用超高液相色谱法进行血浆IgG N-聚糖的检测与分析。IgG N-聚糖的组间比较采用Mann-WhitneyU秩和检验;使用多因素logistic回归分析在调整混杂因素后,探讨心理应激与IgG N-聚糖的关联性;采用Spearman秩相关进行IgG N-聚糖水平与心理应激水平的关联性分析。结果在心理应激高分组中GP4和GP8的水平相比正常组显著升高,G2水平显著降低,差异具有统计学意义(P< 0.05)。心理应激程度与GP3、GP4、GP8和G0呈正相关关系,与GP12、GP14、GP17、GP18、G2、Stotal及S1呈负相关关系(P< 0.05),整体表现为IgG半乳糖基化和唾液酸化修饰水平与心理应激程度呈负相关关系。结论山东某高校大学生疫情期间心理应激反应与IgG N-聚糖存在关联性。IgG N-聚糖所反映的半乳糖基化和唾液酸化修饰水平可能通过改变IgG的炎症效能影响心理应激反应的程度。
王猛, 李培瑞, 卢新霞, 王英杰, 纪龙, 李晓梅, 丁国永, 齐艳波, 邢薇佳, 侯海峰, 王芳, 邓阳, 李栋. 新冠肺炎疫情期间山东省高校大学生心理应激反应与免疫球蛋白G N-聚糖的相关性[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(12): 911-917.
Meng WANG, Peirui LI, Xinxia LU, Yingjie WANG, Long JI, Xiaomei LI, Guoyong DING, Yanbo QI, Weijia XING, Haifeng HOU, Fang WANG, Yang DENG, Dong LI. Association between psychological stress response and IgG N-glycan among the students of a university in Shandong Province during COVID-19 epidemic[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2022, 43(12): 911-917.
基本特征 | 总人群(n= 150) | 高分组(n= 38) | 正常组(n= 112) | t/χ2 | P |
---|---|---|---|---|---|
年龄(岁) | 20.13 ± 1.41 | 20.05 ± 1.39 | 20.16 ± 1.42 | 0.408 | 0.684 |
性别 | 0.430 | 0.512 | |||
男性 | 45 (30.00) | 13 (34.21) | 32 (28.57) | ||
女性 | 105 (70.00) | 25 (65.79) | 80 (71.43) | ||
教育层次 | 0.072 | 0.789 | |||
本科 | 108 (72.00) | 28 (73.68) | 80 (71.43) | ||
专科 | 42 (28.00) | 10 (26.32) | 32 (28.57) | ||
区域疫情流行状况 | 2.374 | 0.305 | |||
上升趋势 | 42 (28.00) | 14 (36.84) | 28 (25.00) | ||
趋于缓和 | 82 (54.67) | 17 (44.74) | 65 (58.04) | ||
无疫情 | 26 (17.33) | 7 (18.42) | 19 (16.96) | ||
家庭所在社区疫情情况 | 8.540 | 0.014 | |||
有确诊/疑似病例 | 27 (18.00) | 10 (26.32) | 17 (15.18) | ||
有密切接触者 | 17 (11.33) | 8 (21.05) | 9 (8.04) | ||
无上述情况 | 106 (70.67) | 20 (52.63) | 86 (76.78) | ||
特质应对方式(分) | |||||
积极应对 | 27.51 ± 8.49 | 26.37 ± 6.68 | 27.90 ± 9.02 | 1.113 | 0.269 |
消极应对 | 20.63 ± 7.00 | 25.29 ± 7.08 | 19.04 ± 6.26 | 4.835 | < 0.001 |
焦虑状况(分) | |||||
状态焦虑 | 39.27 ± 10.98 | 44.34 ± 6.95 | 37.55 ± 11.57 | 4.324 | < 0.001 |
特质焦虑 | 41.51 ± 8.64 | 46.61 ± 6.48 | 39.78 ± 8.62 | 5.133 | < 0.001 |
应激压力反应(分) | |||||
情绪反应 | 17.75 ± 6.33 | 26.00 ± 7.01 | 14.96 ± 2.49 | 9.506 | < 0.001 |
躯体反应 | 12.67 ± 4.35 | 18.24 ± 4.20 | 10.78 ± 2.29 | 10.433 | < 0.001 |
行为反应 | 9.81 ± 3.31 | 13.55 ± 3.64 | 8.54 ± 1.97 | 8.110 | < 0.001 |
SRQ总分 | 43.07 ± 13.40 | 61.53 ± 13.38 | 36.8 ± 5.02 | 11.125 | < 0.001 |
表1新冠肺炎疫情期间在校大学生的基本特征[xˉ± s,n(%)]
基本特征 | 总人群(n= 150) | 高分组(n= 38) | 正常组(n= 112) | t/χ2 | P |
---|---|---|---|---|---|
年龄(岁) | 20.13 ± 1.41 | 20.05 ± 1.39 | 20.16 ± 1.42 | 0.408 | 0.684 |
性别 | 0.430 | 0.512 | |||
男性 | 45 (30.00) | 13 (34.21) | 32 (28.57) | ||
女性 | 105 (70.00) | 25 (65.79) | 80 (71.43) | ||
教育层次 | 0.072 | 0.789 | |||
本科 | 108 (72.00) | 28 (73.68) | 80 (71.43) | ||
专科 | 42 (28.00) | 10 (26.32) | 32 (28.57) | ||
区域疫情流行状况 | 2.374 | 0.305 | |||
上升趋势 | 42 (28.00) | 14 (36.84) | 28 (25.00) | ||
趋于缓和 | 82 (54.67) | 17 (44.74) | 65 (58.04) | ||
无疫情 | 26 (17.33) | 7 (18.42) | 19 (16.96) | ||
家庭所在社区疫情情况 | 8.540 | 0.014 | |||
有确诊/疑似病例 | 27 (18.00) | 10 (26.32) | 17 (15.18) | ||
有密切接触者 | 17 (11.33) | 8 (21.05) | 9 (8.04) | ||
无上述情况 | 106 (70.67) | 20 (52.63) | 86 (76.78) | ||
特质应对方式(分) | |||||
积极应对 | 27.51 ± 8.49 | 26.37 ± 6.68 | 27.90 ± 9.02 | 1.113 | 0.269 |
消极应对 | 20.63 ± 7.00 | 25.29 ± 7.08 | 19.04 ± 6.26 | 4.835 | < 0.001 |
焦虑状况(分) | |||||
状态焦虑 | 39.27 ± 10.98 | 44.34 ± 6.95 | 37.55 ± 11.57 | 4.324 | < 0.001 |
特质焦虑 | 41.51 ± 8.64 | 46.61 ± 6.48 | 39.78 ± 8.62 | 5.133 | < 0.001 |
应激压力反应(分) | |||||
情绪反应 | 17.75 ± 6.33 | 26.00 ± 7.01 | 14.96 ± 2.49 | 9.506 | < 0.001 |
躯体反应 | 12.67 ± 4.35 | 18.24 ± 4.20 | 10.78 ± 2.29 | 10.433 | < 0.001 |
行为反应 | 9.81 ± 3.31 | 13.55 ± 3.64 | 8.54 ± 1.97 | 8.110 | < 0.001 |
SRQ总分 | 43.07 ± 13.40 | 61.53 ± 13.38 | 36.8 ± 5.02 | 11.125 | < 0.001 |
IgG N-聚糖 | 总人群(n= 150) | 高分组(n= 38) | 正常组(n= 112) | Z | P |
---|---|---|---|---|---|
初始聚糖 | |||||
GP1 | 0.08 (0.06 ~ 0.10) | 0.08 (0.06 ~ 0.11) | 0.08 (0.07 ~ 0.10) | 0.250 | 0.802 |
GP2 | 0.22 (0.15 ~ 0.30) | 0.22 (0.15 ~ 0.34) | 0.22 (0.15 ~ 0.28) | 0.279 | 0.780 |
GP3 | 0.13 (0.10 ~ 0.18) | 0.18 (0.12 ~ 0.23) | 0.13 (0.10 ~ 0.16) | 3.310 | 0.001 |
GP4 | 16.47 (14.32 ~ 18.83) | 17.68 (15.80 ~ 19.08) | 16.13 (14.08 ~ 18.59) | 2.109 | 0.035 |
GP5 | 0.14 (0.09 ~ 0.18) | 0.14 (0.10 ~ 0.21) | 0.13 (0.09 ~ 0.17) | 1.348 | 0.178 |
GP6 | 3.11 (2.77 ~ 3.62) | 3.25 (2.76 ~ 3.83) | 3.11 (2.77 ~ 3.50) | 0.659 | 0.510 |
GP7 | 0.26 (0.19 ~ 0.37) | 0.25 (0.19 ~ 0.36) | 0.26 (0.18 ~ 0.38) | 0.417 | 0.677 |
GP8 | 18.67 (17.75 ~ 19.66) | 19.50 (17.83 ~ 20.19) | 18.55 (17.74 ~ 19.53) | 2.372 | 0.018 |
GP9 | 9.49 (8.68 ~ 10.36) | 9.39 (8.96 ~ 10.04) | 9.55 (8.66 ~ 10.55) | 0.104 | 0.917 |
GP10 | 3.48 (3.08 ~ 3.91) | 3.35 (2.99 ~ 4.04) | 3.50 (3.15 ~ 3.91) | 0.447 | 0.655 |
GP11 | 0.58 (0.51 ~ 0.69) | 0.58 (0.53 ~ 0.74) | 0.57 (0.51 ~ 0.68) | 0.862 | 0.388 |
GP12 | 0.79 (0.59 ~ 1.07) | 0.75 (0.53 ~ 0.96) | 0.82 (0.59 ~ 1.10) | 1.435 | 0.151 |
GP13 | 0.26 (0.21 ~ 0.32) | 0.28 (0.22 ~ 0.34) | 0.26 (0.21 ~ 0.32) | 0.785 | 0.432 |
GP14 | 19.49 (17.75 ~ 21.44) | 18.43 (16.64 ~ 20.38) | 19.62 (17.97 ~ 21.70) | 2.478 | 0.013 |
GP15 | 1.47 (1.22 ~ 1.62) | 1.38 (1.16 ~ 1.56) | 1.48 (1.23 ~ 1.67) | 1.381 | 0.167 |
GP16 | 2.72 (2.45 ~ 3.02) | 2.76 (2.50 ~ 3.03) | 2.68 (2.44 ~ 3.02) | 0.458 | 0.647 |
GP17 | 0.95 (0.82 ~ 1.09) | 0.92 (0.78 ~ 1.04) | 0.97 (0.86 ~ 1.11) | 1.679 | 0.093 |
GP18 | 12.83 (11.59 ~ 14.12) | 12.62 (11.38 ~ 13.57) | 13.06 (11.69 ~ 14.20) | 1.262 | 0.207 |
GP19 | 2.00 (1.82 ~ 2.24) | 2.06 (1.84 ~ 2.38) | 1.98 (1.82 ~ 2.20) | 1.240 | 0.215 |
GP20 | 0.16 (0.11 ~ 0.22) | 0.15 (0.10 ~ 0.20) | 0.17 (0.11 ~ 0.23) | 1.010 | 0.313 |
GP21 | 0.88 (0.75 ~ 0.97) | 0.86 (0.77 ~ 0.96) | 0.88 (0.74 ~ 0.98) | 0.532 | 0.595 |
GP22 | 0.16 (0.12 ~ 0.19) | 0.15 (0.12 ~ 0.17) | 0.16 (0.12 ~ 0.19) | 0.970 | 0.332 |
GP23 | 2.80 (2.39 ~ 3.14) | 2.72 (2.41 ~ 3.05) | 2.81 (2.37 ~ 3.20) | 0.324 | 0.746 |
GP24 | 1.95 (1.68 ~ 2.19) | 1.92 (1.73 ~ 2.18) | 1.95 (1.68 ~ 2.21) | 0.279 | 0.780 |
衍生指标 | |||||
GPN | 75.59 (73.43 ~ 77.22) | 75.58 (74.24 ~ 77.19) | 75.59 (73.37 ~ 77.23) | 0.562 | 0.574 |
Stotal | 24.28 (22.51 ~ 26.12) | 24.31 (22.27 ~ 25.44) | 24.29 (22.52 ~ 26.29) | 0.927 | 0.354 |
S1 | 18.47 (17.10 ~ 20.01) | 18.30 (17.28 ~ 19.29) | 18.62 (17.05 ~ 20.12) | 0.938 | 0.348 |
S2 | 5.78 (5.22 ~ 6.32) | 5.57 (5.22 ~ 6.20) | 5.80 (5.21 ~ 6.33) | 0.806 | 0.420 |
G0 | 20.11 (17.63 ~ 22.79) | 21.63 (19.54 ~ 22.84) | 19.49 (17.45 ~ 22.78) | 1.990 | 0.047 |
G1 | 32.74 (31.76 ~ 33.83) | 33.06 (31.79 ~ 34.11) | 32.64 (31.71 ~ 33.72) | 1.385 | 0.166 |
G2 | 21.98 (20.14 ~ 24.35) | 20.65 (19.00 ~ 23.12) | 22.45 (20.39 ~ 24.72) | 2.608 | 0.009 |
F | 95.92 (95.16 ~ 96.65) | 95.84 (95.21 ~ 96.49) | 95.93 (95.02 ~ 96.66) | 0.194 | 0.846 |
B | 13.44 (12.31 ~ 14.42) | 13.35 (12.57 ~ 14.68) | 13.52 (12.31 ~ 14.35) | 0.207 | 0.836 |
表2新冠肺炎疫情期间在校大学生中不同应激水平组间IgG N-聚糖的水平比较
IgG N-聚糖 | 总人群(n= 150) | 高分组(n= 38) | 正常组(n= 112) | Z | P |
---|---|---|---|---|---|
初始聚糖 | |||||
GP1 | 0.08 (0.06 ~ 0.10) | 0.08 (0.06 ~ 0.11) | 0.08 (0.07 ~ 0.10) | 0.250 | 0.802 |
GP2 | 0.22 (0.15 ~ 0.30) | 0.22 (0.15 ~ 0.34) | 0.22 (0.15 ~ 0.28) | 0.279 | 0.780 |
GP3 | 0.13 (0.10 ~ 0.18) | 0.18 (0.12 ~ 0.23) | 0.13 (0.10 ~ 0.16) | 3.310 | 0.001 |
GP4 | 16.47 (14.32 ~ 18.83) | 17.68 (15.80 ~ 19.08) | 16.13 (14.08 ~ 18.59) | 2.109 | 0.035 |
GP5 | 0.14 (0.09 ~ 0.18) | 0.14 (0.10 ~ 0.21) | 0.13 (0.09 ~ 0.17) | 1.348 | 0.178 |
GP6 | 3.11 (2.77 ~ 3.62) | 3.25 (2.76 ~ 3.83) | 3.11 (2.77 ~ 3.50) | 0.659 | 0.510 |
GP7 | 0.26 (0.19 ~ 0.37) | 0.25 (0.19 ~ 0.36) | 0.26 (0.18 ~ 0.38) | 0.417 | 0.677 |
GP8 | 18.67 (17.75 ~ 19.66) | 19.50 (17.83 ~ 20.19) | 18.55 (17.74 ~ 19.53) | 2.372 | 0.018 |
GP9 | 9.49 (8.68 ~ 10.36) | 9.39 (8.96 ~ 10.04) | 9.55 (8.66 ~ 10.55) | 0.104 | 0.917 |
GP10 | 3.48 (3.08 ~ 3.91) | 3.35 (2.99 ~ 4.04) | 3.50 (3.15 ~ 3.91) | 0.447 | 0.655 |
GP11 | 0.58 (0.51 ~ 0.69) | 0.58 (0.53 ~ 0.74) | 0.57 (0.51 ~ 0.68) | 0.862 | 0.388 |
GP12 | 0.79 (0.59 ~ 1.07) | 0.75 (0.53 ~ 0.96) | 0.82 (0.59 ~ 1.10) | 1.435 | 0.151 |
GP13 | 0.26 (0.21 ~ 0.32) | 0.28 (0.22 ~ 0.34) | 0.26 (0.21 ~ 0.32) | 0.785 | 0.432 |
GP14 | 19.49 (17.75 ~ 21.44) | 18.43 (16.64 ~ 20.38) | 19.62 (17.97 ~ 21.70) | 2.478 | 0.013 |
GP15 | 1.47 (1.22 ~ 1.62) | 1.38 (1.16 ~ 1.56) | 1.48 (1.23 ~ 1.67) | 1.381 | 0.167 |
GP16 | 2.72 (2.45 ~ 3.02) | 2.76 (2.50 ~ 3.03) | 2.68 (2.44 ~ 3.02) | 0.458 | 0.647 |
GP17 | 0.95 (0.82 ~ 1.09) | 0.92 (0.78 ~ 1.04) | 0.97 (0.86 ~ 1.11) | 1.679 | 0.093 |
GP18 | 12.83 (11.59 ~ 14.12) | 12.62 (11.38 ~ 13.57) | 13.06 (11.69 ~ 14.20) | 1.262 | 0.207 |
GP19 | 2.00 (1.82 ~ 2.24) | 2.06 (1.84 ~ 2.38) | 1.98 (1.82 ~ 2.20) | 1.240 | 0.215 |
GP20 | 0.16 (0.11 ~ 0.22) | 0.15 (0.10 ~ 0.20) | 0.17 (0.11 ~ 0.23) | 1.010 | 0.313 |
GP21 | 0.88 (0.75 ~ 0.97) | 0.86 (0.77 ~ 0.96) | 0.88 (0.74 ~ 0.98) | 0.532 | 0.595 |
GP22 | 0.16 (0.12 ~ 0.19) | 0.15 (0.12 ~ 0.17) | 0.16 (0.12 ~ 0.19) | 0.970 | 0.332 |
GP23 | 2.80 (2.39 ~ 3.14) | 2.72 (2.41 ~ 3.05) | 2.81 (2.37 ~ 3.20) | 0.324 | 0.746 |
GP24 | 1.95 (1.68 ~ 2.19) | 1.92 (1.73 ~ 2.18) | 1.95 (1.68 ~ 2.21) | 0.279 | 0.780 |
衍生指标 | |||||
GPN | 75.59 (73.43 ~ 77.22) | 75.58 (74.24 ~ 77.19) | 75.59 (73.37 ~ 77.23) | 0.562 | 0.574 |
Stotal | 24.28 (22.51 ~ 26.12) | 24.31 (22.27 ~ 25.44) | 24.29 (22.52 ~ 26.29) | 0.927 | 0.354 |
S1 | 18.47 (17.10 ~ 20.01) | 18.30 (17.28 ~ 19.29) | 18.62 (17.05 ~ 20.12) | 0.938 | 0.348 |
S2 | 5.78 (5.22 ~ 6.32) | 5.57 (5.22 ~ 6.20) | 5.80 (5.21 ~ 6.33) | 0.806 | 0.420 |
G0 | 20.11 (17.63 ~ 22.79) | 21.63 (19.54 ~ 22.84) | 19.49 (17.45 ~ 22.78) | 1.990 | 0.047 |
G1 | 32.74 (31.76 ~ 33.83) | 33.06 (31.79 ~ 34.11) | 32.64 (31.71 ~ 33.72) | 1.385 | 0.166 |
G2 | 21.98 (20.14 ~ 24.35) | 20.65 (19.00 ~ 23.12) | 22.45 (20.39 ~ 24.72) | 2.608 | 0.009 |
F | 95.92 (95.16 ~ 96.65) | 95.84 (95.21 ~ 96.49) | 95.93 (95.02 ~ 96.66) | 0.194 | 0.846 |
B | 13.44 (12.31 ~ 14.42) | 13.35 (12.57 ~ 14.68) | 13.52 (12.31 ~ 14.35) | 0.207 | 0.836 |
IgG N-聚糖 | 情绪反应 | 躯体反应 | 行为反应 | SRQ总得分 | ||||
---|---|---|---|---|---|---|---|---|
r | P | r | P | r | P | r | P | |
GP1 | -0.040 | 0.623 | -0.129 | 0.115 | -0.014 | 0.865 | -0.065 | 0.429 |
GP2 | 0.085 | 0.299 | 0.085 | 0.299 | -0.042 | 0.606 | 0.064 | 0.438 |
GP3 | 0.218 | 0.007 | 0.135 | 0.100 | 0.148 | 0.070 | 0.185 | 0.024 |
GP4 | 0.262 | 0.001 | 0.225 | 0.006 | 0.191 | 0.019 | 0.272 | 0.001 |
GP5 | 0.053 | 0.522 | 0.052 | 0.528 | 0.046 | 0.580 | 0.047 | 0.567 |
GP6 | 0.101 | 0.220 | 0.143 | 0.081 | 0.057 | 0.489 | 0.135 | 0.099 |
GP7 | -0.031 | 0.707 | 0.021 | 0.796 | -0.057 | 0.490 | -0.014 | 0.866 |
GP8 | 0.143 | 0.080 | 0.182 | 0.026 | 0.168 | 0.039 | 0.171 | 0.037 |
GP9 | 0.051 | 0.539 | -0.027 | 0.743 | 0.127 | 0.121 | 0.060 | 0.466 |
GP10 | -0.034 | 0.683 | -0.064 | 0.434 | 0.004 | 0.963 | -0.038 | 0.648 |
GP11 | 0.063 | 0.445 | -0.073 | 0.372 | 0.079 | 0.335 | 0.023 | 0.782 |
GP12 | -0.175 | 0.032 | -0.116 | 0.156 | -0.219 | 0.007 | -0.180 | 0.028 |
GP13 | 0.065 | 0.427 | 0.051 | 0.535 | 0.030 | 0.719 | 0.055 | 0.503 |
GP14 | -0.290 | < 0.001 | -0.255 | 0.002 | -0.189 | 0.021 | -0.285 | < 0.001 |
GP15 | -0.130 | 0.113 | -0.166 | 0.042 | -0.056 | 0.496 | -0.140 | 0.088 |
GP16 | 0.067 | 0.416 | 0.037 | 0.656 | 0.057 | 0.486 | 0.069 | 0.401 |
GP17 | -0.156 | 0.057 | -0.115 | 0.162 | -0.219 | 0.007 | -0.171 | 0.037 |
GP18 | -0.172 | 0.035 | -0.147 | 0.072 | -0.215 | 0.008 | -0.205 | 0.012 |
GP19 | 0.109 | 0.183 | 0.009 | 0.914 | 0.121 | 0.141 | 0.056 | 0.498 |
GP20 | -0.034 | 0.677 | -0.085 | 0.303 | -0.051 | 0.535 | -0.063 | 0.445 |
GP21 | -0.071 | 0.387 | -0.030 | 0.716 | -0.087 | 0.288 | -0.080 | 0.333 |
GP22 | -0.044 | 0.594 | -0.024 | 0.770 | -0.086 | 0.296 | -0.058 | 0.484 |
GP23 | -0.049 | 0.554 | -0.010 | 0.900 | -0.100 | 0.222 | -0.062 | 0.449 |
GP24 | -0.071 | 0.388 | -0.027 | 0.747 | -0.025 | 0.762 | -0.076 | 0.357 |
GPN | 0.119 | 0.145 | 0.094 | 0.253 | 0.160 | 0.051 | 0.153 | 0.061 |
Stotal | -0.142 | 0.083 | -0.128 | 0.119 | -0.191 | 0.019 | -0.186 | 0.023 |
S1 | -0.142 | 0.084 | -0.134 | 0.102 | -0.197 | 0.016 | -0.184 | 0.024 |
S2 | -0.109 | 0.184 | -0.059 | 0.471 | -0.122 | 0.138 | -0.126 | 0.126 |
G0 | 0.242 | 0.003 | 0.222 | 0.006 | 0.176 | 0.031 | 0.259 | 0.010 |
G1 | 0.115 | 0.163 | 0.092 | 0.262 | 0.198 | 0.015 | 0.141 | 0.086 |
G2 | -0.296 | < 0.001 | -0.248 | 0.002 | -0.203 | 0.013 | -0.289 | < 0.001 |
F | 0.002 | 0.982 | -0.029 | 0.722 | 0.089 | 0.277 | 0.018 | 0.832 |
B | 0.023 | 0.783 | -0.038 | 0.642 | 0.036 | 0.665 | 0.010 | 0.907 |
表3新冠肺炎疫情期间在校大学生IgG-N聚糖水平与SRQ各维度及总得分的Spearman相关性分析
IgG N-聚糖 | 情绪反应 | 躯体反应 | 行为反应 | SRQ总得分 | ||||
---|---|---|---|---|---|---|---|---|
r | P | r | P | r | P | r | P | |
GP1 | -0.040 | 0.623 | -0.129 | 0.115 | -0.014 | 0.865 | -0.065 | 0.429 |
GP2 | 0.085 | 0.299 | 0.085 | 0.299 | -0.042 | 0.606 | 0.064 | 0.438 |
GP3 | 0.218 | 0.007 | 0.135 | 0.100 | 0.148 | 0.070 | 0.185 | 0.024 |
GP4 | 0.262 | 0.001 | 0.225 | 0.006 | 0.191 | 0.019 | 0.272 | 0.001 |
GP5 | 0.053 | 0.522 | 0.052 | 0.528 | 0.046 | 0.580 | 0.047 | 0.567 |
GP6 | 0.101 | 0.220 | 0.143 | 0.081 | 0.057 | 0.489 | 0.135 | 0.099 |
GP7 | -0.031 | 0.707 | 0.021 | 0.796 | -0.057 | 0.490 | -0.014 | 0.866 |
GP8 | 0.143 | 0.080 | 0.182 | 0.026 | 0.168 | 0.039 | 0.171 | 0.037 |
GP9 | 0.051 | 0.539 | -0.027 | 0.743 | 0.127 | 0.121 | 0.060 | 0.466 |
GP10 | -0.034 | 0.683 | -0.064 | 0.434 | 0.004 | 0.963 | -0.038 | 0.648 |
GP11 | 0.063 | 0.445 | -0.073 | 0.372 | 0.079 | 0.335 | 0.023 | 0.782 |
GP12 | -0.175 | 0.032 | -0.116 | 0.156 | -0.219 | 0.007 | -0.180 | 0.028 |
GP13 | 0.065 | 0.427 | 0.051 | 0.535 | 0.030 | 0.719 | 0.055 | 0.503 |
GP14 | -0.290 | < 0.001 | -0.255 | 0.002 | -0.189 | 0.021 | -0.285 | < 0.001 |
GP15 | -0.130 | 0.113 | -0.166 | 0.042 | -0.056 | 0.496 | -0.140 | 0.088 |
GP16 | 0.067 | 0.416 | 0.037 | 0.656 | 0.057 | 0.486 | 0.069 | 0.401 |
GP17 | -0.156 | 0.057 | -0.115 | 0.162 | -0.219 | 0.007 | -0.171 | 0.037 |
GP18 | -0.172 | 0.035 | -0.147 | 0.072 | -0.215 | 0.008 | -0.205 | 0.012 |
GP19 | 0.109 | 0.183 | 0.009 | 0.914 | 0.121 | 0.141 | 0.056 | 0.498 |
GP20 | -0.034 | 0.677 | -0.085 | 0.303 | -0.051 | 0.535 | -0.063 | 0.445 |
GP21 | -0.071 | 0.387 | -0.030 | 0.716 | -0.087 | 0.288 | -0.080 | 0.333 |
GP22 | -0.044 | 0.594 | -0.024 | 0.770 | -0.086 | 0.296 | -0.058 | 0.484 |
GP23 | -0.049 | 0.554 | -0.010 | 0.900 | -0.100 | 0.222 | -0.062 | 0.449 |
GP24 | -0.071 | 0.388 | -0.027 | 0.747 | -0.025 | 0.762 | -0.076 | 0.357 |
GPN | 0.119 | 0.145 | 0.094 | 0.253 | 0.160 | 0.051 | 0.153 | 0.061 |
Stotal | -0.142 | 0.083 | -0.128 | 0.119 | -0.191 | 0.019 | -0.186 | 0.023 |
S1 | -0.142 | 0.084 | -0.134 | 0.102 | -0.197 | 0.016 | -0.184 | 0.024 |
S2 | -0.109 | 0.184 | -0.059 | 0.471 | -0.122 | 0.138 | -0.126 | 0.126 |
G0 | 0.242 | 0.003 | 0.222 | 0.006 | 0.176 | 0.031 | 0.259 | 0.010 |
G1 | 0.115 | 0.163 | 0.092 | 0.262 | 0.198 | 0.015 | 0.141 | 0.086 |
G2 | -0.296 | < 0.001 | -0.248 | 0.002 | -0.203 | 0.013 | -0.289 | < 0.001 |
F | 0.002 | 0.982 | -0.029 | 0.722 | 0.089 | 0.277 | 0.018 | 0.832 |
B | 0.023 | 0.783 | -0.038 | 0.642 | 0.036 | 0.665 | 0.010 | 0.907 |
1 | 王一, 高俊岭, 陈浩, 等. 2019冠状病毒病(COVID-19)疫情期间公众媒体暴露及其与心理健康的关系[J]. 复旦学报(医学版), 2020, 47(2): 173. |
2 | 邱小英, 张琳娜, 褚成静. 特质正念对新冠肺炎疫情引发的应激反应及负面情绪的缓冲作用[J]. 中华全科医学, 2021, 19(8): 1390. |
3 | Rohleder N. Stress and inflammation - The need to address the gap in the transition between acute and chronic stress effects[J]. Psychoneuroendocrinology, 2019, 105: 164. |
4 | McEwen BS. Protective and damaging effects of stress mediators[J]. N Engl J Med, 1998, 338(3): 171. |
5 | Black PH. Stress and the inflammatory response: a review of neurogenic inflammation[J]. Brain Behav Immun, 2002, 16(6): 622. |
6 | Couzin-Frankel J. Inflammation bares a dark side[J]. Science, 2010, 330(6011): 1621. |
7 | Krištić J, Lauc G. Ubiquitous importance of protein glycosylation[J]. Methods Mol Biol, 2017, 1503: 1. |
8 | 张芳, 许之珏, 徐颖姣, 等. IgG糖基化与疾病相关性研究进展[J]. 生命科学, 2017, 29(4): 319. |
9 | Masuda K, Kubota T, Kaneko E, et al. Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity[J]. Mol Immunol, 2007, 44(12): 3122. |
10 | Wu Z, Pan H, Liu D, et al. Variation of IgG N-linked glycosylation profile in diabetic retinopathy[J]. J Diabetes, 2021, 13(8): 672. |
11 | Vučković F, Krištić J, Gudelj I, et al. Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome[J]. Arthritis Rheumatol, 2015, 67(11): 2978. |
12 | Ren S, Zhang Z, Xu C, et al. Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types[J]. Cell Res, 2016, 26(8): 963. |
13 | Lemmers RFH, Vilaj M, Urda D, et al. IgG glycan patterns are associated with type 2 diabetes in independent European populations[J]. Biochim Biophys Acta Gen Subj, 2017, 1861(9): 2240. |
14 | Russell AC, Šimurina M, Garcia MT, et al. TheN-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease[J]. Glycobiology, 2017, 27(5): 501. |
15 | 张勤, 王丹妮, 姚荣英, 等. 蚌埠市大学生特质应对方式及相关因素研究[J]. 中华疾病控制杂志, 2014, 18(11): 1083. |
16 | 周永安, 赵静波, 张小远. 广东高校大学生状态、特质焦虑状况及影响因素[J]. 现代预防医学, 2013, 40(3): 489. |
17 | 曹亚杰, 司继伟. 大学生生活事件应对方式与应激反应关系研究[J]. 中国学校卫生, 2010, 31(1): 53. |
18 | Wang M, Chen X, Tang Z, et al. Association between immunoglobulin GN-glycosylation and vascular cognitive impairment in a sample with atherosclerosis: a case-control study[J]. Front Aging Neurosci, 2022, 14: 823468. |
19 | Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health[J]. Nat Rev Immunol, 2005, 5(3): 243. |
20 | Benedetti E, Pučić-Baković M, Keser T, et al. Network inference from glycoproteomics data reveals new reactions in the IgG glycosylation pathway[J]. Nat Commun, 2017, 8(1): 1483. |
21 | Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases[J]. Cell Immunol, 2018, 333: 65. |
22 | Böhm S, Schwab I, Lux A, et al. The role of sialic acid as a modulator of the anti-inflammatory activity of IgG[J]. Semin Immunopathol, 2012, 34(3): 443. |
23 | Peschke B, Keller CW, Weber P, et al. Fc-galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity[J]. Front Immunol, 2017, 8: 646. |
24 | Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression[J]. Psychol Bull, 2014, 140(3): 774. |
25 | Rohleder N. Stimulation of systemic low-grade inflammation by psychosocial stress[J]. Psychosom Med, 2014, 76(3): 181. |
26 | 李硕硕, 刘谦东, 袁增强. 创伤后应激障碍生物学基础及治疗研究进展[J]. 中国药理学与毒理学杂志, 2017, 31(12): 1185. |
27 | Silverman MN, Pearce BD, Biron CA, et al. Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection[J]. Viral Immunol, 2005, 18(1): 41. |
28 | Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses[J]. Endocr Rev, 1996, 17(1): 64. |
29 | Hänsel A, Hong S, Cámara RJ, et al. Inflammation as a psychophysiological biomarker in chronic psychosocial stress[J]. Neurosci Biobehav Rev, 2010, 35(1): 115. |
[1] | 杨琰, 周典, 田帝, 接纯纯, 汪恒, 周苑, 吴烨.休闲运动的态度行为对大学生亚健康的影响[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(4): 282-286. |
[2] | 张小凤.综合护理干预对罹患焦虑症在校大学生的焦虑评分及睡眠质量的效果研究[J]. betway必威登陆网址 (betway.com )学报, 2021, 42(2): 142-144. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||